comparing glp-1 agonists Comparative features of glucagon-like peptide 1-receptor Mapping the effectiveness and risks
Description
16: e66691
Interestingly, while tirzepatide acts as an agonist of the GLP-1 receptor, it may effectively act as a GIP receptor antagonist
The SURMOUNT-4 trial showed even steeper rebounds with tirzepatide, with participants regaining more than 50% of their weight loss over 52 weeks after stopping
Medication Shortages Patients lost progress when they couldnt access prescriptions
GIPR Antagonists It has been reported that the insulinotropic effect of GIP is severely compromised in patients with obesity-diabetes [115], although the effect is partially restored after optimization of glucose regulation through intensified insulin therapy [116]
Wegovy Adults and adolescents (12-plus) with obesity (BMI 30)
